Syntheses and evaluation of halogenated cytisine derivatives and of bioisosteric thiocytisine as potent and selective nAChR ligands.

PubWeight™: 1.12‹?› | Rank: Top 10%

🔗 View Article (PMID 11461763)

Published in Eur J Med Chem on April 01, 2001

Authors

P Imming1, P Klaperski, M T Stubbs, G Seitz, D Gündisch

Author Affiliations

1: Department of Pharmaceutical Chemistry, Philipps-University, Marbacher Weg 6, D-35032 Marburg, Germany.

Articles by these authors

Endoscopic mucosal resection of early cancer and high-grade dysplasia in Barrett's esophagus. Gastroenterology (2000) 2.66

The SSX-2 gene, which is involved in the t(X;18) translocation of synovial sarcomas, codes for the human tumor antigen HOM-MEL-40. Cancer Res (1996) 1.93

Human carbonic anhydrase XII: cDNA cloning, expression, and chromosomal localization of a carbonic anhydrase gene that is overexpressed in some renal cell cancers. Proc Natl Acad Sci U S A (1998) 1.92

Poorly differentiated colonic adenocarcinoma, medullary type: clinical, phenotypic, and molecular characteristics. Am J Pathol (1997) 1.73

Identification of a meiosis-specific protein as a member of the class of cancer/testis antigens. Proc Natl Acad Sci U S A (1998) 1.68

5-Iodo-A-85380, an alpha4beta2 subtype-selective ligand for nicotinic acetylcholine receptors. Mol Pharmacol (2000) 1.67

Crystal structures of the membrane-binding C2 domain of human coagulation factor V. Nature (1999) 1.58

The ornithodorin-thrombin crystal structure, a key to the TAP enigma? EMBO J (1996) 1.53

Nephron sparing surgery for synchronous bilateral nephroblastoma involving the renal hilus. J Urol (2011) 1.47

[Limited surgical radicality in occult cancer of Vater's papilla]. Langenbecks Arch Chir (1991) 1.40

Casein kinase II is elevated in solid human tumours and rapidly proliferating non-neoplastic tissue. Eur J Biochem (1990) 1.38

Abnormal osteogenesis in osteoporotic patients is reflected by altered mesenchymal stem cells dynamics. J Cell Biochem (1999) 1.37

KTP laser destruction of dysplasia and early cancer in columnar-lined Barrett's esophagus. Gastrointest Endosc (1999) 1.28

Expression of multiple cancer/testis (CT) antigens in breast cancer and melanoma: basis for polyvalent CT vaccine strategies. Int J Cancer (1998) 1.25

Expression of SSX genes in human tumors. Int J Cancer (1998) 1.24

Late pulmonary metastasis in uterine PEComa. J Clin Pathol (2003) 1.20

Histopathological diagnosis of Barrett's mucosa and associated neoplasias: results of a consensus conference of the Working Group for Gastroenterological Pathology of the German Society for Pathology on 22 September 2001 in Erlangen. Virchows Arch (2003) 1.11

Factorising ligand affinity: a combined thermodynamic and crystallographic study of trypsin and thrombin inhibition. J Mol Biol (2001) 1.09

Lysine 156 promotes the anomalous proenzyme activity of tPA: X-ray crystal structure of single-chain human tPA. EMBO J (1997) 1.08

Specificity of antibodies directed against Env protein of human endogenous retroviruses in patients with germ cell tumors. Cancer Res (1996) 1.08

Stromal expression of c-Ets1 transcription factor correlates with tumor invasion. Cancer Res (1994) 1.08

Comparative analysis of haemostatic proteinases: structural aspects of thrombin, factor Xa, factor IXa and protein C. Thromb Haemost (1997) 1.06

2-, 5-, and 6-Halo-3-(2(S)-azetidinylmethoxy)pyridines: synthesis, affinity for nicotinic acetylcholine receptors, and molecular modeling. J Med Chem (1998) 1.04

The thrombin E192Q-BPTI complex reveals gross structural rearrangements: implications for the interaction with antithrombin and thrombomodulin. EMBO J (1997) 1.04

Telomeric associations and loss of telomeric DNA repeats in renal tumors. Genes Chromosomes Cancer (1993) 1.03

Optimum prediction of three-way crosses from single crosses in forage maize (Zea mays L.). Theor Appl Genet (1987) 1.03

Structural and functional analyses of benzamidine-based inhibitors in complex with trypsin: implications for the inhibition of factor Xa, tPA, and urokinase. J Med Chem (1998) 0.99

Differential expression of mucins and trefoil peptides in native epithelium, Barrett's metaplasia and squamous cell carcinoma of the oesophagus. J Cancer Res Clin Oncol (1999) 0.99

Isolation and characterization of the human mismatch repair gene hMSH2 promoter region. Hum Genet (1996) 0.98

Microsatellite instability in sporadic carcinomas of the proximal colon: association with diploid DNA content, negative protein expression of p53, and distinct histomorphologic features. Surgery (1998) 0.98

A new target for shigellosis: rational design and crystallographic studies of inhibitors of tRNA-guanine transglycosylase. J Mol Biol (2001) 0.98

Healing of lymphocytic gastritis after Helicobacter pylori eradication therapy--a randomized, double-blind, placebo-controlled multicentre trial. Aliment Pharmacol Ther (2006) 0.97

A case of aortic valve disease associated with Tropheryma whippelii infection in the absence of other signs of Whipple's disease. Infection (2001) 0.96

Expression of the breast cancer associated gene pS2 and the pancreatic spasmolytic polypeptide gene (hSP) in diffuse type of stomach carcinoma. Eur J Cancer (1991) 0.95

High levels of nm23-H1 and nm23-H2 messenger RNA in human squamous-cell lung carcinoma are associated with poor differentiation and advanced tumor stages. Int J Cancer (1993) 0.94

Increased detectability of somatic changes in the DNA from human tumours after probing with "synthetic" and "genome-derived" hypervariable multilocus probes. Hum Genet (1989) 0.94

Investigations of the estrogen (ER-ICA-test) and the progesterone receptor in the prostate and prostatic carcinoma on immunohistochemical basis. Virchows Arch A Pathol Anat Histopathol (1988) 0.94

Immunohistochemical investigation of different cytokeratins and vimentin in the prostate from the fetal period up to adulthood and in prostate carcinoma. Pathol Res Pract (1987) 0.92

Association of the human spasmolytic polypeptide and an estrogen-induced breast cancer protein (pS2) with human pancreatic carcinoma. Lab Invest (1992) 0.92

Hepatic reperfusion injury following orthotopic liver transplantation in the rat. Transplantation (1988) 0.92

The second Kunitz domain of human tissue factor pathway inhibitor: cloning, structure determination and interaction with factor Xa. J Mol Biol (1997) 0.92

Carcinosarcoma of the lung, a tumour which has a poor prognosis and is extremely rarely diagnosed preoperatively. Thorac Cardiovasc Surg (1990) 0.91

6-[18F]fluoro-A-85380, a novel radioligand for in vivo imaging of central nicotinic acetylcholine receptors. Life Sci (2000) 0.91

Detection of neuroblastoma cells in CD34+ selected peripheral stem cells using a combination of tyrosine hydroxylase nested RT-PCR and anti-ganglioside GD2 immunocytochemistry. Eur J Cancer (1997) 0.90

Morphological and immunohistochemical investigations of the utriculus prostaticus from the fetal period up to adulthood. Prostate (1990) 0.90

Reverse transcriptase-polymerase chain reaction (RT-PCR) analysis of monoamine transporters in neuroblastoma cell lines: correlations to meta-iodobenzylguanidine (MIBG) uptake and tyrosine hydroxylase gene expression. Eur J Cancer (1995) 0.90

Decreased cardiac concentration of cGMP kinase in hypertensive animals. An index for cardiac vascularization? Circ Res (1989) 0.89

Expression of calpain I messenger RNA in human renal cell carcinoma: correlation with lymph node metastasis and histological type. Int J Cancer (1999) 0.89

A two-colour technique for chromosome in situ hybridization in tissue sections. J Pathol (1992) 0.87

Synthesis and evaluation of diazine containing bioisosteres of (-)-ferruginine as ligands for nicotinic acetylcholine receptors. Bioorg Med Chem (2001) 0.85

Expression of the nm23 homologues nm23-H4, nm23-H6, and nm23-H7 in human gastric and colon cancer. J Pathol (2005) 0.85

Spatial structure of thrombin as a guide to its multiple sites of interaction. Semin Thromb Hemost (1993) 0.84

Glucocorticoid therapy obscures the diagnosis of cerebral lymphoma. Acta Neuropathol (1990) 0.84

Alteration of mitochondrial DNA in human oncocytomas. Genes Chromosomes Cancer (1989) 0.84

Structural mapping of the active site specificity determinants of human tissue-type plasminogen activator. Implications for the design of low molecular weight substrates and inhibitors. J Biol Chem (1997) 0.84

The 'female prostate': location, morphology, immunohistochemical characteristics and significance. Eur Urol (1992) 0.84

[Histopathological diagnosis of Barrett's mucosa and associated neoplasias. Results of a consensus conference of the Working Group for "Gastroenterological Pathology of the German Society for Pathology" on 22 September 2001]. Pathologe (2003) 0.83

Imaging of central nAChReceptors with 2-[18F]F-A85380: optimized synthesis and in vitro evaluation in Alzheimer's disease. Appl Radiat Isot (2004) 0.83

3-Amidinophenylalanine-based inhibitors of urokinase. Bioorg Med Chem Lett (1999) 0.83

Nephrogenic adenoma of the bladder in a child--immunohistochemical and lectinhistochemical investigations. Eur Urol (1990) 0.83

Sonographic diagnosis of a carcinoid tumour of the appendix in a 14-year-old boy. Ultraschall Med (2003) 0.83

Curative treatment for high-grade intraepithelial neoplasia in Barrett's esophagus. Endoscopy (2005) 0.83

The structure of the human betaII-tryptase tetramer: fo(u)r better or worse. Proc Natl Acad Sci U S A (1999) 0.82

Mutagenesis and crystallographic studies of Zymomonas mobilis tRNA-guanine transglycosylase to elucidate the role of serine 103 for enzymatic activity. FEBS Lett (1999) 0.82

Efficient in vitro generation of adult multipotent cells from mobilized peripheral blood CD133+ cells. Cell Prolif (2008) 0.82

The prognostic value of Bcl-XL gene expression for remission induction is influenced by cytogenetics in adult acute myeloid leukemia. Haematologica (2001) 0.82

Endoscopic ultrasonography of the mediastinum in the diagnosis of bronchial carcinoma. Thorac Cardiovasc Surg (1991) 0.81

Genotypic characterization of prostatic carcinomas: a combined cytogenetic, flow cytometry, and in situ DNA hybridization study. Cancer Res (1993) 0.81

Tumor-specific methylation patterns of erbB2 (HER2/neu) sequences in gastro-intestinal cancer. Anticancer Res (1992) 0.80

2-[18F]F-A-85380: a PET radioligand for alpha4beta2 nicotinic acetylcholine receptors. Neuroreport (1999) 0.80

Clonal chromosome aberrations in three of five sporadic angiomyolipomas of the kidney. Cancer Genet Cytogenet (1997) 0.80

A second trefoil protein, ITF/hP1.B, is transcribed in human breast cancer. Breast Cancer Res Treat (1996) 0.80

Syntheses of novel pyridazinomorphinans by inverse electron demand cycloaddition and their binding to mu and kappa receptors. Arch Pharm (Weinheim) (1997) 0.80

A simple and fast method for the preparation of n.c.a. 2-[18F]F-A85380 for human use. Appl Radiat Isot (2005) 0.79

["Inverse" Diels-Alder additions, VIII: azepines as "inverse" dienophiles (author's transl)]. Arch Pharm (Weinheim) (1978) 0.79

Structural and energetic determinants for enantiopreferences in kinetic resolution of lipases. Protein Eng (2003) 0.79

Catalytic domain structure of vampire bat plasminogen activator: a molecular paradigm for proteolysis without activation cleavage. Biochemistry (1997) 0.79

[Heterotopic gastric mucosa of the rectum]. Pathologe (1987) 0.79

Crystallization of phycoerythrin 545 of Rhodomonas lens using detergents and unusual additives. Protein Sci (1998) 0.79

Isolation and characterization of new microsatellites at the nm23-H1 and nm23-H2 gene loci and application for loss of heterozygosity (LOH) analysis. Hum Genet (1997) 0.78

Hairpin loop mutations of chicken cystatin have different effects on the inhibition of cathepsin B, cathepsin L and papain. FEBS Lett (1995) 0.78

Bilateral multicentric papillary renal tumors with heteroclonal origin based on tissue-specific karyotype instability. Cancer (1993) 0.78

Photooxygenation of the helimers of (-)-isocolchicine: regio- and facial selectivity of the [4 + 2] cycloaddition with singlet oxygen and surprising endoperoxide transformations. J Org Chem (2001) 0.78

exo-2-(Pyridazin-4-yl)-7-azabicyclo[2.2.1]heptanes: syntheses and nicotinic acetylcholine receptor agonist activity of potent pyridazine analogues of (+/-)-epibatidine. J Med Chem (2001) 0.78

A new approach to duct management in pancreatic transplantation: temporary occlusion with fibrin sealing and enterostomies. Transplant Proc (1987) 0.78

Temporary inhibition of papain by hairpin loop mutants of chicken cystatin. Distorted binding of the loops results in cleavage of the Gly(9)-Ala10 bond. FEBS Lett (1995) 0.78

Genetic changes and telomerase activity in human renal cell carcinoma. Clin Cancer Res (1998) 0.77

Rearrangement of chromosome 1 is a frequent finding in endometrial carcinoma. An in situ hybridization study in nine endometrial carcinomas. Cancer Genet Cytogenet (1995) 0.77

Effects of cytisine on hydroxyl radicals in vitro and MPTP-induced dopamine depletion in vivo. Eur J Pharmacol (1998) 0.77

Histology and immunohistochemistry studies in prostate cancer. Am J Clin Oncol (1988) 0.77

Expression of the c-erbB2 proto-oncogene in male breast carcinoma: lack of prognostic significance. Oncology (1993) 0.77

Overexpression of nm23-H4 RNA in colorectal and renal tumours. Anticancer Res (2001) 0.77

Crystallographic evidence that the F2 kringle catalytic domain linker of prothrombin does not cover the fibrinogen recognition exosite. J Biol Chem (1996) 0.77

Retrospective analysis of prognostic significance of the estrogen-inducible pS2 gene in male breast carcinoma. Cancer (1993) 0.77

MALT lymphoma associated genetic aberrations occur at different frequencies in primary and secondary intestinal MALT lymphomas. Gut (2006) 0.77

Development of a 5-hydroxytryptamine(2A) receptor binding assay for high throughput screening using 96-well microfilter plates. J Biomol Screen (2000) 0.77

Bisquaternary caracurine V and iso-caracurine V salts as ligands for the muscle type of nicotinic acetylcholine receptors: SAR and QSAR studies. Bioorg Med Chem (2004) 0.77

Functional analysis of P-glycoprotein and multidrug resistance associated protein related multidrug resistance in AML-blasts. Leuk Res (1999) 0.77